Chronic pain: Levorphanol, methadone, and the N-methyl-d-aspartate receptor

Journal of Palliative Medicine

Volumn 12, Issue 9, 2009, Pages 765-766

  McNulty, Jack P ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; GABAPENTIN; GLUTAMIC ACID; KETAMINE; LEVORPHANOL; METHADONE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PREGABALIN; N METHYLASPARTIC ACID; NARCOTIC AGENT; NARCOTIC ANALGESIC AGENT;

ADJUVANT THERAPY; ANALGESIC ACTIVITY; CHRONIC PAIN; CONSTIPATION; DISEASE SEVERITY; DRUG MECHANISM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HOSPICE CARE; HUMAN; LETTER; MAJOR CLINICAL STUDY; NEUROPATHIC PAIN; QT PROLONGATION; RECEPTOR BLOCKING; SEDATION; SIDE EFFECT; TREATMENT RESPONSE; ANTAGONISTS AND INHIBITORS; CHRONIC DISEASE; DRUG EFFECTS; PAIN; PALLIATIVE THERAPY;

ANALGESICS, OPIOID; CHRONIC DISEASE; HOSPICE CARE; HUMANS; LEVORPHANOL; METHADONE; N-METHYLASPARTATE; NARCOTICS; PAIN; PALLIATIVE CARE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 70350118084     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2009.0105     Document Type: Letter

References (19)

1. Annetta MG, Iemma D, Garisto C, Tafani C, Proietti R: Ketamine: New indications for an old drug. Curr Drug Targets 2005;6:789-794.
2. Ayonrinde OT, Bridge DT: The rediscovery of methadone for cancer pain management. Med J Aust 2000;173:536-540.
3. Baumrucker SJ: Politics, cancer pain, and methadone. Am J Hosp Palliat Med 2000;17:153-154.
4. Brookoff D: Chronic pain: 1. A new disease? Hosp Pract (Minneap) 2000;35:45-52, 59.
5. Brookoff D: Chronic pain: 2. The case for opioids. Hosp Pract (Minneap) 2000;35:69-72, 75-76, 81-84.
6. Bruera E, Sweeney C: Methadone use in cancer patients with pain: A review. J Palliat Med 2002;5:127-138.
7. Carr DB, Goudas LC, Denman WT, Brookoff D, Lavin PT, Staats PS: Safety and efficacy of intranasal ketamine in a mixed population with chronic pain. Pain 2004;110:762-764.
8. Fine P: Ketamine: From anesthesia to palliative care. AAHPM Bull 2003;3(3):1, 6.
9. Fischberg D: State of the Science Lecture: Update in hospice and palliative care. Paper presented at: Annual Assembly of the American Academy of Hospice and Palliative Medicine, Plenary Session III. Phoenix, AZ: January 25, 2004.
10. Foley KM: Opioids and chronic neuropathic pain. N Engl J Med 2003;348:1279-1281.
11. Gourevitch MN: First do no harm ... reduction? Ann Intern Med 2009;150:417-418.
12. Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC: QTc interval screening in methadone treatment. Ann Intern Med 2009;150:387-395.
13. Kronenberg RH: Ketamine as an analgesic: Parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration. J Pain Palliat Care Pharmacother 2002;16:27-35.
14. McNulty JP: Can levorphanol be used like methadone for intractable refractory pain? J Palliat Med 2007;10:293-296.
15. McNulty JP: Levorphanol for the treatment of severe chronic pain. IJPC 2007;11:202-211.
16. McNulty JP: Update on managing neuropathic pain. IJPC 2009; 13:182-190.
17. Poyhia R, Vainio A: Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia. Clin J Pain 2006; 22:32-36.
18. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D: Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003;348:1223-1232.
19. Wheeler WL, Dickerson ED: Clinical applications of methadone. Am J Hosp Palliat Med 2000;17:196-203.